Functional genomics of transgenic overexpression of A1 adenosine receptors in the heart

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 402-409

  Gauthier, Naomi S ^a   Ray Morrison, R ^a   Byford, Anne M ^a   Jones, Rachael ^a   Headrick, John P ^a   Paul Matherne, G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

A1 receptor; Adenosine; Genomics; Myocardial protection; Transgenic

Indexed keywords

ADENOSINE A1 RECEPTOR; BETA ADRENERGIC RECEPTOR; ISOPRENALINE;

ANIMAL MODEL; ANIMAL TISSUE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE OVEREXPRESSION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INOTROPISM; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; TRANSGENIC MOUSE;

EID: 0032468122     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<402::AID-DDR41>3.0.CO;2-7     Document Type: Conference Paper

References (32)

1. Bellardinelli L, Linden J, Berne RM. 1989. The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
2. th, Hickey RE 1995. The role of ATP sensitive potassium channels in myocardial protection. J Cardiac Surg 10:441-444.
3. Cerbai E, Guerra L, Varani K, Barbieri M, Borea PA, Mugelli A. 1995. Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: A combined patch-clamp and binding study. Br J Pharmacol 116:1835-1842.
4. Dobson JG Jr, Ordway RW, Fenton RA. 1986. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol 251:H455-H462.
5. Dobson JG Jr, Fenton RA, Romano FD. 1987. The cardiac anti-adrenergic effect of adenosine. Prog Clin Biol Res 230:331-343.
6. Downey JM, Liu GS, Thomton JD. 1993. Adenosine and the antiinfarct effects of preconditioning. Cardiovasc Res 27:3-8.
7. Downey JM, Cohen MV, Ytrehus K, Liu K. 1994. Cellular mechanisms in ischémie preconditioning: The role of adenosine and protein kinase C. Ann NY Acad Sci 723:82-98.
8. Ely SW, Berne RM. 1992. Protective effects of adenosine in myocardial ischemia. Circulation 85:893-904.
9. Fenton RA, Galeckas KJ, Dobson JG 1995. Endogenous adenosine reduces depression of cardiac function induced by ß-adrenergic stimulation during low flow perfusion. J Mol Cell Cardiol 27:23732383.
10. 1 adenosine receptors. J Mol Cell Cardiol 30:187-193.
11. GauthierNS, Matherne GP, Morrison RR, Headrick JR 1998b. Determination of function in the isolated working mouse heart: Issues in experimental design. J Mol Cell Cardiol 30:453-461.
12. Hadcock JR, Malbon CC. 1988. Down-regulation of ß-adrenergic receptors: Agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 85:5021-5025.
13. Hadcock JR, Port JD, Malbon CC. 1991. Cross-regulation between G-protein-mediated pathways. J Biol Chem 266:11915-11922.
14. Headrick JE 1996a. Ischémie preconditioning: Bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28:1227-12240.
15. Headrick JR 1996b. Interstitial adenosine and function in rat heart in vivo: Effects of adrenaline and 8-cycIopentyl-l,3-dimethylxanthine. Clin Exp Phannacol Physiol 23(5):3S6-394.
16. 1 adenosine receptor overexpression markedly improves myocarclial energy state during ischemia-reperfusion. J Mol Cell Cardiol 30:1059-1064.
17. Hearse DJ. 1995. Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection? Cardiovasc Res 30:1-17.
18. Hieter P, Boguski M. 1997. Functional-genomics: It's all in how you read it. Science 278:601-602.
19. Krege JH, Hodgin JB, Hagaman JR, Smithies 0.1995. A noninvasive computerized tail-cuffsystem for measuring blood pressure in mice. Hypertension 25:1111-1115.
20. 1 receptor mediation. Am J Physiol 263:H1460-H1465.
21. 1 receptor mediated protection of the globally ischémie isolated rat heart. J Mol Cell Cardiol 22:39-47.
22. 1 adenosine receptors in rabbit heart. Circulation 84:350-356.
23. 1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Nail Acad Sci USA 94:65416546.
24. Miura T, limura O. 1993. Infarct size limitation by preconditioning: Its phenomenological features and the key role of adenosine. Cardiovasc Res 27:36-42.
25. Newby AC. 1984. Adenosine and the concept of 'retaliatory' metabolites.' Trends Biochem Sci 9:42-14.
26. Pell TJ, Yellon DM, Goodwin RW, Baxter GE 1997. Myocardial ischémie tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc Drugs Ther 11:679-686.
27. Romano FD, Dobson JG 1996. Adenosine attenuation of isoproterenol-stimulated adenylyl cyclase activity is enhanced with aging in the adult heart. Life Sci 58:493-502
28. Romano FD, Naimi TS, Dobson JG 1991. Adenosine attenuation of catecholamine-enhanced contractility of rat heart in vivo. Am J Physiol 260:II1635-H1639.
29. Roth DA, White CD, Podolin DA, Mazzeo RS. 1998. Alterations in myocardial signal transduction due to aging and chronic dynamic exercise. J Appl Physiol 84:177-184.
30. Vander Heide RS, Reimer KA. 1996. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31:711-718.
31. White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, et al. 1994. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90:1225-1238.
32. Zhao ZQ, McGee S, Nakanishi K, Toombs CF, Johnston WE, Ashar MS, Vinten-Johansen J. 1993. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88:709-719.